Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_assertion type Assertion NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_head.
- NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_assertion description "[Thus, OBP-401 in combination with docetaxel efficiently enhances the antitumor efficacy both in vitro and in vivo, and the outcome has important implications for tumor-specific oncolytic chemovirotherapies for human cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_provenance.
- NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_assertion evidence source_evidence_literature NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_provenance.
- NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_assertion SIO_000772 16477640 NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_provenance.
- NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_assertion wasDerivedFrom befree-20150227 NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_provenance.
- NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_assertion wasGeneratedBy ECO_0000203 NP526792.RAGImtKqeg557pyNcvf1xMniM_0C39dcCo3AUDRKj-Xoo130_provenance.